There are 1105 resources available
Close
Presenter: Elizabeth Connolly, Hongcheng Zhu, Matteo Lambertini
Session: Young Oncologists clinical cases discussion
Resources:
Webcast
128MO - Final overall survival for the phase III, KEYNOTE-811 study of pembrolizumab plus trastuzumab and chemotherapy for HER2+ advanced, unresectable or metastatic G/GEJ adenocarcinoma
Presenter: Sun Young Rha
Session: Mini Oral session: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
LBA2 - Belzutifan versus everolimus for previously treated advanced clear cell renal cell carcinoma (ccRCC): Updated follow-up of the East Asian subgroup of the randomized phase III LITESPARK-005 trial
Presenter: Jae-Lyun Lee
Session: Proffered Paper session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast
Management of germinomas in Europe (GCTIII)
Presenter: Didier Frappaz
Session: Intracranial germ cell tumors in East Asia and Europe
Resources:
Slides
Webcast
402O - Preliminary results of phase II study to evaluate safety and efficacy of combination pucotenlimab with epidermal growth factor receptor-ADC (EGFR-ADC) MRG003 in recurrent or metastatic nasopharyngeal carcinoma (R/M-NPC)
Presenter: Danyun Ruan
Session: Proffered Paper session: Head and neck cancers
Resources:
Abstract
Slides
Webcast
Changing treatment landscape for HER2+ mBC
Presenter: Janice Wing-Hang Tsang
Session: Emerging diagnostics and systemic treatments for patients with metastatic breast cancer (mBC)
Resources:
Slides
Webcast
The Patient Dignity Inventory (PDI) in oncology and palliative care
Presenter: Deepa Natarajan
Session: Diversity and inclusion in supportive and palliative care
Resources:
Slides
Webcast
Efficacy of low-dose ICI
Presenter: Amol Patel
Session: Optimising immune checkpoint inhibitors (ICI) treatment in advanced melanoma
Resources:
Slides
Webcast
129MO - Trastuzumab deruxtecan (T-DXd) in Chinese patients (pts) with previously treated HER2-positive (HER2+) advanced gastric or gastroesophageal junction adenocarcinoma (GEJA): DESTINY-Gastric06 (DG-06) final analysis
Presenter: Zhi Peng
Session: Mini Oral session: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
268O - Determinants of neoadjuvant immune checkpoint inhibitor plus tyrosine kinase inhibitor therapy response in renal cell carcinoma
Presenter: Liangyou Gu
Session: Proffered Paper session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast